https://www.selleckchem.com/pr....oducts/pf-06826647.h
Folic acid-doxorubicin-double-functionalized-lipid-core nanocapsules (LNC-CS- -Zn -DOX-FA) were prepared, characterized, and evaluated in vitro against ovarian and bladder cancer cell lines (OVCAR-3 and T24). LNC-CS- -Zn -DOX-FA was prepared by self-assembly and interfacial reactions, and characterized using liquid chromatography, particle sizing, transmission electron microscopy, and infrared spectroscopy. Cell viability and cellular uptake were studied using MTT assay and confocal microscopy. The presence of lecithin allows the fo